Template:ENHANCE Polling Results

Only practicing physicians are requested to vote. Caution: This is not a valid scientific poll.

How do the results of ENHANCE change your Vytorin prescribing practices? I will increase my prescriptions given the cholesterol lowering benefits No impact I will decrease my prescriptions by 10% I will decrease my prescriptions by 25% I will decrease my prescriptions by 50% or more I will no longer prescribe Vytorin

Do the results of a negative imaging trial in a restricted cohort of patients alter your outlook on Vytorin? Yes, if the imaging trials are negative in a subpopulation of patients, this is sufficient information to make a decision regarding the efficacy in my patients No, I will wait to evaluate the results of large clinical trials with clinical endpoints before I make a decision regarding the efficacy in my patients

Will the combination of Ezetimibe and a statin ultimately replace statin monotherapy? Yes No

What percentage of your hypercholesterolemic patients who you would currently treat with a statin alone would you instead treat with Ezetimibe in combination with a statin? 0-20% 21-40% 41-60% 61-80% 81-90% 91-100%

When you are evaluating a new drug, what drives your decision making process? Surrogate imaging endpoints Clinical endpoints Cost